UPDATE: RBC Capital Downgrades Neurocrine Bio. (NBIX) to Sector Perform
Tweet Send to a Friend
(Updated - January 18, 2022 6:39 AM EST)
RBC Capital analyst Brian Abrahams downgraded Neurocrine Bio. (NASDAQ: NBIX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Brian Abrahams downgraded Neurocrine Bio. (NASDAQ: NBIX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
